The Hague | The European Medicines Agency (EMA) announced on Tuesday that it had received an application for authorization for the AstraZeneca / Oxford vaccine against the new coronavirus, specifying that it could make its decision on January 29.
“The EMA has received a request for authorization for a conditional marketing of the vaccine against COVID-19 developed by AstraZeneca and the University of Oxford,” said the European agency based in Amsterdam, in a statement .
The EMA already authorized the Pfizer / BioNTech COVID-19 vaccine on December 21 and the Moderna vaccine on January 6, for which the European Commission immediately gave the green light.
The agency said it would conduct an expedited review, with a decision that could be made on Jan. 29, if the data reported is “robust and complete” enough.
The European Union and EMA are under pressure to speed up approval of new vaccines against the virus, which has already claimed more than 620,000 lives across the continent.